Physician profile
Thomas Bolt
NPI 1639136377
$6,603.40
in general payments reported to CMS, 2019-2025
53 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,237 · 2020: $1,000 · 2021: $1,535 · 2022: $1,260 · 2023: $338 · 2024: $104 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $571.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $833.80 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $505.72 | 2019-2022 | |
| Novo Nordisk INC | $491.00 | 2019-2023 | Ozempic, Rybelsus |
| Amgen INC. | $465.61 | 2019-2024 | Krystexxa, Prolia, Evenity |
| Pfizer INC. | $463.88 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $380.92 | 2019-2022 | |
| Abbvie INC. | $285.51 | 2021-2025 | Vraylar |
| Teva Pharmaceuticals USA, INC. | $263.10 | 2019-2020 | |
| Astellas Pharma US INC | $218.34 | 2019-2022 | |
| Inari Medical, INC. | $194.33 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Merck Sharp & Dohme LLC | $192.47 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $176.36 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $173.98 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $158.87 | 2019-2022 | |
| Lilly USA, LLC | $157.50 | 2019-2023 | Mounjaro |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Bolt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.